MSD Contact Information Legal Terms MSD Jobs
MESO SCALE DISCOVERY
MESO SCALE DISCOVERY
Catalog
MULTI-ARRAY Detection Technology
Products
Literature & Publications
Applications Literature
Brochures
Customer Presentations
MSD Assay Product Inserts
Technical & Application Notes
MSD Publication References
Our Company
Purchase MSD Assays
Shows & Events We Attend
 



Publications

IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adult.

Leng, S.X., Tian, X., Matteini, A., Li, H., Hughes, J., Jain, A., Walston, J.D., Fedarko, N.S.

Journal Age Ageing. Year 2011
Species Human Volume 40 (4)
IL-6 Page # 475-481
Matrix Tested Serum Cytokines & Chemokines

Abstract

BACKGROUND: Neopterin is a monocyte/macrophage-derived immune activation marker and its levels increase with age. Frailty is an important clinical syndrome of old age. Previous studies have shown significant association between elevated interleukin-6 (IL-6) levels and frailty. The objective of this study was to evaluate IL-6-independent association of serum neopterin levels with prevalent frailty.

METHODS: this is a cross-sectional study in community-dwelling older adults recruited from residential and retirement communities in Baltimore, MD, USA. Frailty was determined using validated screening criteria. Serum neopterin and IL-6 levels were measured using standard enzyme-linked immunosorbent assay. Pearson correlation and multivariate linear regression analysis was performed to assess the relationship between log(neopterin) and log(IL-6). Odds ratios (ORs) for frailty were calculated using log(neopterin) and log(IL-6) as continuous measures and across tertiles of neopterin and IL-6 levels, adjusting for age, race, sex, education and body mass index.

RESULTS: one hundred and thirty-three individuals with a mean age of 84 years (range 72-97) completed the study. Neopterin levels were significantly higher in frail older adults than those in non-frail controls [median: 8.94 versus 8.35 nM, respectively, P < 0.001 t-test on log(neopterin)]. Log(neopterin) was significantly associated with prevalent frailty, adjusting for log(IL-6). Participants in the top tertile of neopterin had OR of 3.80 [95% confidence interval (CI) = 1.36-10.6, P < 0.01] for frailty. As expected, participants in the top tertile of IL-6 had OR of 3.29 (95% CI = 1.21-7.86, P < 0.05) for frailty. Log(neopterin) correlated with log(IL-6) (correlation coefficient = 0.19, P < 0.05). Moreover, OR for participants in the top neopterin tertile remained significant after adjusting for IL-6 (OR = 3.97, 95% CI = 1.15-13.72, P < 0.05).

CONCLUSION: elevated neopterin levels had IL-6-independent association with prevalent frailty, suggesting potential monocyte/macrophage-mediated immune activation in the frail elderly.

View Publication


Related Products
Human Demonstration 10-Plex Base Kit
Human Demonstration 10-Plex Tissue Culture Kit
Human Demonstration 4-Plex Base Kit
Human Demonstration 4-Plex Tissue Culture Kit
Human Demonstration 7-Plex Base Kit
Human Demonstration 7-Plex Tissue Culture Kit
Human ProInflammatory 7-Plex Base Kit
Human ProInflammatory 7-Plex Tissue Culture Kit
Human ProInflammatory 7-Plex Ultra-Sensitive Kit
Human ProInflammatory 9-Plex Base Kit

view more

Suggest a Reference


Speak with a Scientist



CAREERS     |     CONTACT US     |     LEGAL     |     PRIVACY
Feedback Form
Feedback Analytics